ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,660Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 680

$1M Total Retail Price of All Prescriptions

Rank: 81 out of 680

1,034 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 1,034 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 21,767 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 1,451 1,392 1 3
LEVOTHYROXINE SODIUM 1,150 1,082 2 2
AMLODIPINE BESYLATE 996 929 3 1
LISINOPRIL 938 876 4 5
METFORMIN HCL 653 583 5 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 615 550 6 37
HYDROCHLOROTHIAZIDE 552 533 7 9
FUROSEMIDE 545 503 8 6
HYDROCODONE-ACETAMINOPHEN 521 480 S3 9 4
ATORVASTATIN CALCIUM 512 459 10 11
OMEPRAZOLE 491 448 11 7
TAMSULOSIN HCL 433 422 12 34
PRAVASTATIN SODIUM 373 327 13 10
ZOLPIDEM TARTRATE 350 317 14 17
FENOFIBRATE 322 282 15 66
METOPROLOL SUCCINATE 319 314 16 13
ATENOLOL 312 269 17 19
ALENDRONATE SODIUM 305 300 18 32
CITALOPRAM HBR 299 283 19 22
CRESTOR 275 227 20 25
METOPROLOL TARTRATE 262 252 21 12
MELOXICAM 262 244 21 24
GLYBURIDE-METFORMIN HCL 260 235 R 23 107
SYNTHROID 251 240 24 38
CARVEDILOL 243 236 25 23
PANTOPRAZOLE SODIUM 234 220 26 30
DOXAZOSIN MESYLATE 232 231 27 73
NEXIUM 227 190 28 16
POTASSIUM CHLORIDE 227 210 28 14
GABAPENTIN 225 212 30 15
QUINAPRIL HCL 215 215 31 104
FINASTERIDE 206 206 32 109
NAMENDA 200 200 33 35
FLUTICASONE PROPIONATE 195 172 34 41
DICLOFENAC SODIUM 192 148 35 162
DONEPEZIL HCL 191 191 36 27
VERAPAMIL ER 184 171 37 100
TRAMADOL HCL 183 154 38 18
BENAZEPRIL HCL 177 172 39 40
TRAZODONE HCL 162 135 40 48
WARFARIN SODIUM 161 160 41 20
ALLOPURINOL 156 144 42 33
DIGOXIN 153 153 43 58
CLOPIDOGREL 150 147 44 26
TRICOR 147 121 45 98
BENAZEPRIL-HYDROCHLOROTHIAZIDE 146 134 46 164
LOSARTAN POTASSIUM 145 137 47 21
SERTRALINE HCL 140 125 48 28
GLIPIZIDE 138 127 49 63
LANTUS SOLOSTAR 136 115 50 84
CLONIDINE HCL 125 125 51 36
GLYBURIDE 123 111 R 52 85
LOSARTAN-HYDROCHLOROTHIAZIDE 123 117 52 51
AMITRIPTYLINE HCL 119 89 R 54 47
ACTOS 117 117 55 114
KLOR-CON M20 116 104 56 61
ATENOLOL-CHLORTHALIDONE 116 101 56 205
LIPITOR 112 109 58 68
ROPINIROLE HCL 108 99 59 99
TRIAMTERENE-HCTZ 105 94 60 52
LOVASTATIN 105 105 60 44
VESICARE 102 88 62 176
RANITIDINE HCL 99 85 63 56
PLAVIX 97 97 64 39
AMLODIPINE BESYLATE-BENAZEPRIL 95 86 65 43
GEMFIBROZIL 91 79 66 106
ESTRADIOL 89 87 R 67 134
CELEBREX 83 60 68 90
PAROXETINE HCL 83 68 68 76
ALPRAZOLAM 83 83 68 72
ESCITALOPRAM OXALATE 72 57 71 45
BYSTOLIC 71 71 72 79
GLIMEPIRIDE 66 62 73 29
ZETIA 65 47 74 87
RAMIPRIL 65 65 74 69
MECLIZINE HCL 64 62 76 103
TERAZOSIN HCL 60 60 77 180
FOSINOPRIL SODIUM 58 58 78 203
NADOLOL 58 54 78 315
DILTIAZEM 24HR CD 57 45 80 182
SPIRIVA 55 44 81 70
PEN NEEDLE 54 40 82 122
FLUOXETINE HCL 53 40 83 74
ISOSORBIDE MONONITRATE ER 53 50 83 59
KLOR-CON M10 51 51 85 127
ADVAIR DISKUS 50 46 86 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.